Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20+ B Cell Lymphoma.
TRANSPLANTATION AND CELLULAR THERAPY(2024)
关键词
ACTR707,Cellular therapy,Rituximab,Lymphoma,CD20
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要